Effects of Inhibitors of Plasminogen Activator, Serine Proteinases, and Collagenase IV on the Invasion of Basement Membranes by Metastatic Cells

Cancer Research

Volumn 48, Issue 12, 1988, Pages 3307-3312

  Reich, Reuven ^a   Thompson, Erik W ^a   Iwamoto, Yukihide ^a   Martin, George R ^a   Deason, James R ^b   Fuller, George C ^b   Miskin, Ruth ^c  

^a NIH ^*  (United Kingdom)

^b G D Searle Co ^*  (United Kingdom)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIMETASTATIC AGENT; BENZAMIDINE; COLLAGENASE; LODELABEN; PLASMINOGEN ACTIVATOR; SOYBEAN TRYPSIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; BASEMENT MEMBRANE; CANCER INVASION; CELL CULTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN;

ANIMAL; BASEMENT MEMBRANE; ENZYME ACTIVATION; HUMAN; MICE; MICROBIAL COLLAGENASE; NEOPLASM INVASIVENESS; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0023919232     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Nieolson G. L. Organ colonization and the cell-surface properties of malig nant cells Biochim. Biophys. Acta 695:113-176, 1982.
2. Strauli, P. A concept of invasion. In: P. Strauli, A. J. Barrett, and A. Baici (eds.), Proteinases and Tumor Invasion. EORTC Monogr. Ser, Vol. 6, pp. 1-15. New York: Raven Press, 1980.
3. Woolley, D. E. Collagenolytic mechanisms in tumor cell invasion. Cancer Metastasis Rev., 3: 361-372, 1984.
4. Mullins, D. E., and Rohrlich, S. T. The role of proteinases in cellular invasiveness. Biochim. Biophys. Acta, 695:177-214, 1983. 36
5. Fidler, I. J., Gersten, D. M., and Hart, I. R. The biology of cancer invasion and metastases. Adv. Cancer Res., 28: 149-250, 1978. 37
6. Fidler, I. J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res., 38: 2651-2660, 1978.
7. Weiss, L., and Ward, P. M. Cell detachment and metastasis. Cancer Metas- 38, tasis Rev., 2: 111-123, 1983.
8. Hart, I. R. “Seed and soil” revisited: mechanisms of site specific metastasis. Cancer Metastasis Rev., 1: 5-16, 1982. 39.
9. Salsbury, A. J. The significance of the circulating cancer cell. Cancer Treat. Rev., 2: 55-72, 1975.
10. Liotta, L. A. Tumor invasion and metastases: role of the basement membrane. Am. J. Pathol., 117: 339-348, 1984.
11. Poole, A. R., Tutman, K. J., Recklies, A. D., and Stoker, T. A. M. Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature (Lond.), 273: 545-547, 1978.
12. Recklies, A. D., Mort, J. S., and Poole, A. R. Secretion of a thiol proteinase from mouse mammary carcinomas and its characterization. Cancer Res., 42: 1026-1032, 1982.
13. Sloane, B. F., Honn, K. V., Sadler, J. C., Turner, W. A., Kimpson, J. J., and Taylor, J. D. Cathespin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res., 42:980-986, 1982.
14. Robertson, D. M., and Williams, D. C. In vitro evidence for neutral collagen ase activity in an invasive mammalian tumor. Nature (Lond.), 221: 259-260, 1969.
15. Dresden, M. II., Heilman, S. A., and Schmidt, J. D. Collagenolytic enzymes in human neoplasms. Cancer Res., 22: 993-996, 1972.
16. Yamanishi, Y., Maeyens, E., Dabbous, M. K., Ohyama, H., and Hashimoto, K. Collagenolytic activity in malignant melanoma: physicochemical studies. Cancer Res., 33: 2507-2512, 1973.
17. Hashimoto, K., Yamanishi, Y., Maeyens, E., Dabbous, M. K., and Kanzaki, T. Collagenolytic activities of squamous cell carcinoma of the skin. Cancer Res., 33:2790-2801, 1973.
18. Liotta, L. A., Abe, S., Gehron-Robey, P. and Martin, G. R. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc. Nati. Acad. Sci. USA, 76: 2268-2272, 1979.
19. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284: 67-68, 1980.
20. Wirl, G., and Frick, J. Collagenase: a marker enzyme in human bladder cancer. Urol. Res., 7: 103, 1979.
21. Eisenbach, L., Segal, S., and Feldman, M. Proteolytic enzymes in tumor metastasis. II. Collagenase type IV activity in subcellular fractions of cloned tumor cell populations. J. Nati. Cancer Inst., 74: 87-93, 1985.
22. Dano, K., Andreasen, P. A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L. S., and Skriver, L. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res., 44: 139-266, 1985.
23. Persky, B., Ostrowski, L. E., Pagast, P., Ahsan, A., and Schultz, R. M. Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion. Cancer Res., 46:4129-4134, 1986.
24. Ostrowski, L. E., Ahsan, A., Suthar, B. P., Pagasi, P., Bain, D. L., Wong, C., Patel, A., and Schultz, R. M. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis. Cancer Res., 46: 4121-4128, 1986.
25. Lowe, F. C., and Isaacs, J. T. Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the Dunning R-3327 rat prostatic adenocarcinoma system as a model. Cancer Res., 44: 744-752, 1984.
26. Pauli, B. U., Arsemis, C., Hohberger, L. H., and Schwartz, D. E. Connective tissue degradation by invasive rat bladder carcinomas: Action of nonspecific proteinases on collagenous matrices. Cancer Res., 46: 2005-2012, 1986.
27. Zucker, S., Beck, G., DiStefano, J. F., and Lysik, R. M. Role for different cell proteinases in cancer invasion and cytolysis. Br. J. Cancer, 52: 223-232, 1985.
28. Salo, T., Liotta, L. A., Keski-Oja, J., Turpeenniemi-Hujanen, T., and Tryggvason, K. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells—role in metastasis. Int. J. Cancer, 30:669-673, 1982.
29. Cresson, D. H., Beckman, W. C., Tridwell, R. R., Geratz, J. D., and Siegal, G. S. In vitro inhibition of human sarcoma cell's invasive ability by bis(5- amidino 2-benzimidazolyl) methane—a novel esteroprotease inhibitor. Am. J. Pathol., 123:46-56, 1986.
30. Mignatti, P., Robbins, E., and Rifkin, D. B. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell, 47: 487-498, 1986.
31. Ossowski, L., and Reich, E. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell, 35: 611-619, 1983.
32. Marcel, M., Kint, J., and Meyvisch, C. Methods of study of the invasion of malignant C3H mouse fibroblasts into embryonic chick heart in vitro. Virchows Arch. B. Cell Pathol., 30:95-111, 1979.
33. Hart, I. R., and Fidler, I. J. An in vitro quantitative assay for tumor cell invasion. Cancer Res., 38: 3218-3224, 1978.
34. Poste, G., Doll, J., Hart, I. R., and Fidler, I. J. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res., 40: 1636-1644, 1980.
35. Starkey, J. R., Hosick, H. L., Stanford, D. R., and Liggitt, H. D. Interaction of metastatic tumor cells with bovine lens. Cancer Res., 44: 1585-1594, 1984.
36. Ossowski, L., and Reich, E. Experimental model for quantitative study of metastasis. Cancer Res., 40: 2300-2309, 1980.
37. Liotta, L. A., Lee, W. C., and Morakis, D. J. New method for preparing large surfaces of intact basement membrane for tumor invasion studies. Cancer Lett., 11: 141-147, 1980.
38. Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W., and Martin, G. R. Basement membrane complexes with biological activity. Biochemistry, 25: 312-318, 1986.
39. Terranova, V. P., Hujanen, E. S., Loeb, D. M., Martin, G. R., Thornburg, L., and Glushko, V. Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. Proc. Nati. Acad. Sci. USA, 83:465-469, 1986.
40. Kramer, R. H., Bensch, K. K., and Wong, J. Invasion of reconstituted basement membrane matrix by metastatic tumor cells. Cancer Res., 46: 1980-1989, 1986.
41. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M. and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
42. Rasheed, S., Nelson-Rees. W. A., Toth, E. M., Arnstein, P., and Gardner, M. B. Characterization of a newly derived human sarcoma cell line (III 1080). Cancer (Phila.), 33: 1027-1033, 1974.
43. Sykes, J. A., Whitescarver, J., Jernstron, P., Nolan, J. F., and Byatt, P. Some properties of a new epithelial cell line of human origin. J. Nati. Cancer Iusi. 45: 107-122, 1970.
44. Talmadge, J. E., and Fidler, I. J. Enhanced metastatic potential of tumor cells harvested from spontaneous metastasesof heterogenous murine tumors. J. Nati. Cancer Inst., 69:975-980, 1982.
45. Fidler, I. J., Gruys, E., Cifone, M. A., Barnes, Z., and Bucana, C. Demon stration of multiple phenotypic diversity in a murine melanoma of recent origin. J. Nail. Cancer Inst., 67: 947-956, 1981.
46. Fidler, I. J. Selection of successive tumor lines for metastasis. Nat. New Biol., 242: 148-149, 1973.
47. Menzel, J., and Borth, W. Influence of plasma fibronectin on collagen cleavage by collagenase. Collagen Relat. Res., 3: 217-230, 1983.
48. Miskin, R., and Soreq, H. Sensitive autoradiographic quantification of electrophoretically separated proteases. Anal. Biochem., 115: 252-258, 1981.
49. Liotta, L. A., Goldfarb, R. H., Brundage, R., Siegal, G. P., Terranova, V., and Garbisa, S. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement mem brane. Cancer Res., 41:4629-4636, 1981.
50. Liotta. L. A., Goldfarb, R. H., and Terranova, V. P. Cleavage of laminin by thrombin and plasmin:,. iImmillili selectively cleaves the. i chain of laminin. Thromb Res., 21: 663-673, 1981.
51. Paranjpe, M., Engel, L., Young, N., and Liotta, L. A. Activation of human breast carcinoma collagenase through plasminogen activator. Life Sci., 26: 1223-1231, 1980.
52. Moscatelli, D., Rifkin, D. B., Isseroll, R. R., and Jaffe, E. A. Plasminogen activator, plasmin and collagenase interactions. In: P. Strauli, A. J. Barrett, and A. Baici (als.). Proteases and Tumor Invasion. EORTC Monogr., Vol. 6, pp. 143-152. New York: Raven Press, 1980.
53. Markus, G., Camiolo, S. M., Kohga, S., Medeja, J. M., and Mitelman, A. Plasminogen activator secretion of human tumors in short-term organ cul ture, including a comparison of primary and metastatic colon tumors. Cancer Res., 43: 5517-5525, 1983.
54. Camiolo, S. M., Markus, G., Englander, L. S., Suita, M. R., Hobika, G. H., and Kohgen, S. Plasminogen activator content and secretion in expiants of neoplastic and benign human prostate tissues. Cancer Res., 44: 311-318, 1984.
55. Gale, G. R. Antagonism by deoxyribosides of the inhibitory action of certain hydroxamic acids on deoxyribonucleic acid synthesis. Experientia, 24: 57- 58, 1968.
56. Sioane, B. F., Dunn, J. R., and Horn, K. V. Lysosomal cathepsin B. Correlation with metastatic potential. Science (Wash. DC), 212:1151-1152, 1981.
57. Poole, A. R., Recklies, A. D., and Mort, J. S. Secretion of proteinases from human breast tumors: excessive release from carcinomas of a thiol proteinase. In: P. Strauli, A. J. Barrett, and A. Baici (als.). Proteases and Tumor Invasion. European Organization for Research on Treatment of Cancer, Vol. 6, pp. 215-217. New York: Raven Press, 1980.
58. Nakajima, M., Irimura, T., DiFerrante, N., and Nicolson, G. L. Metastatic melanoma cell heparinase. J. Biol. Chem., 259: 2283-2290, 1984.